Asthma

Showing NaN - NaN of 192

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Asthma Trial in Worldwide (AZD4604, Placebo)

Not yet recruiting
  • Asthma
  • Stockton, California
  • +24 more
Aug 25, 2023

Asthma Trial in Worldwide (BFF MDI 160/9.6 µg BID (320/19.2µg/day), BD MDI 160 µg BID (320 µg/day))

Recruiting
  • Asthma
  • BFF MDI 160/9.6 μg BID (320/19.2μg/day)
  • BD MDI 160 μg BID (320 μg/day)
  • Huntington Beach, California
  • +52 more
Mar 9, 2023

Asthma Trial in Worldwide (BGF MDI 320/28.8/9.6 µg, BGF MDI 320/14.4/9.6 µg, BFF MDI 320/9.6 µg)

Recruiting
  • Asthma
  • BGF MDI 320/28.8/9.6 μg
  • +3 more
  • Muscle Shoals, Alabama
  • +387 more
Jan 18, 2023

Asthma Trial in Worldwide (Tezepelumab)

Recruiting
  • Asthma
  • Tezepelumab
  • Newport Beach, California
  • +102 more
Jan 11, 2023

Asthma Trial in Berlin, Belfast (SAR443765, Placebo, Salbutamol or levosalbutamol)

Active, not recruiting
  • Asthma
  • Berlin, Germany
  • +1 more
Jan 6, 2023

Asthma Trial in London, Manchester (Human beta common receptor antagonist mAb, Placebo)

Recruiting
  • Asthma
  • Human beta common receptor antagonist monoclonal antibody
  • Placebo
  • Berlin, Germany
  • +2 more
Dec 21, 2022

Asthma Trial in Worldwide (MEDI3506, Placebo)

Active, not recruiting
  • Asthma
  • MEDI3506
  • Placebo
  • Bakersfield, California
  • +64 more
Dec 19, 2022

Observational Study of Obstructive Lung Disease (NOVELTY)

Active, not recruiting
  • Asthma
  • +2 more
  • Blood draw
  • +3 more
  • Loma Linda, California
  • +302 more
Nov 22, 2022

Asthma Trial in Germany

Active, not recruiting
  • Asthma
    • Aschaffenburg, Germany
    • +51 more
    Nov 3, 2022

    Study on Patterns of Care in Mild Asthmatic Patients

    Completed
    • Asthma
      • Berlin, Germany
      • +58 more
      Sep 26, 2022

      Asthma Trial in Berlin (Reminders and feedback to improve adherence, No reminders and feedback to improve adherence)

      Recruiting
      • Asthma
      • Reminders and feedback to improve adherence
      • No reminders and feedback to improve adherence
      • Berlin, Germany
        MECS Research GmbH
      Sep 21, 2022

      Asthma, Severe Eosinophilic Asthma Trial in Worldwide (Symbicort®, Fasenra®, Ventolin®)

      Active, not recruiting
      • Asthma
      • Severe Eosinophilic Asthma
      • Brest Cedex, France
      • +22 more
      Aug 24, 2022

      Asthma Trial in Worldwide (BFF MDI 320/9.6 µg, BFF MDI 160/9.6 µg, BD MDI 320 µg)

      Recruiting
      • Asthma
      • BFF MDI 320/9.6 μg
      • +3 more
      • Saraland, Alabama
      • +121 more
      Aug 22, 2022

      Asthma Trial in Worldwide (CSJ117, Placebo)

      Recruiting
      • Asthma
      • Bakersfield, California
      • +61 more
      Aug 10, 2022

      Inhalative Therapy in Real- Life Conditions

      Active, not recruiting
      • Asthma
      • MF/IND/GLY plus sensor system
      • FDC therapy
      • Ulm, BW, Germany
      • +25 more
      Aug 10, 2022

      Asthma Trial in Worldwide (AZD5718, Placebo, Montelukast)

      Recruiting
      • Asthma
      • Sheffield, Alabama
      • +176 more
      Jul 12, 2022

      Chronic Rhinosinusitis With Nasal Polyps, Asthma Trial in Worldwide (Dupilumab, Omalizumab, Placebo)

      Recruiting
      • Chronic Rhinosinusitis With Nasal Polyps
      • Asthma
      • Tucson, Arizona
      • +65 more
      Jul 12, 2022

      Asthma Trial in Worldwide (SAR231893, Placebo)

      Recruiting
      • Asthma
      • Bakersfield, California
      • +57 more
      Jul 4, 2022

      Asthma Trial in Worldwide (Benralizumab)

      Completed
      • Asthma
      • Benralizumab
      • Flagstaff, Arizona
      • +143 more
      Jun 22, 2022

      Asthma Trial in Worldwide (MTPS9579A, Placebo)

      Completed
      • Asthma
      • Bakersfield, California
      • +35 more
      May 25, 2022

      Asthma Trial in Worldwide (Dupilumab)

      Completed
      • Asthma
      • Birmingham, Alabama
      • +364 more
      Mar 21, 2022

      Asthma Trial in Worldwide (dupilumab, Matching )

      Recruiting
      • Asthma
      • Rolling Hills Estates, California
      • +29 more
      Mar 18, 2022

      Asthma Trial in Worldwide (Placebo, Brodalumab)

      Terminated
      • Asthma
      • Placebo
      • Brodalumab
      • Birmingham, Alabama
      • +160 more
      Feb 3, 2022

      Asthma Trial in Worldwide (Tezepelumab, Placebo)

      Completed
      • Asthma
      • Tezepelumab
      • Placebo
      • Bakersfield, California
      • +59 more
      Nov 10, 2021